Catalyst Wire Dossier Catalyst Wire Dossier

SPH3127 Tablets

SPH3127 · Shanghai Pharmaceuticals Holding Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPH3127 Tablets, covering 2025-02-19 to 2025-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease [Phase 2]

See pricing